Use: Labeled indications
- INDICATIONS AND USAGE SILVADENE Cream 1% (silver sulfadiazine) is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
Full indications and usage US FDA label
INDICATIONS AND USAGE SILVADENE Cream 1% (silver sulfadiazine) is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.
Contraindications
CONTRAINDICATIONS SILVADENE Cream 1% (silver sulfadiazine) is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. Because sulfonamide therapy is known to increase the possibility of kernicterus, SILVADENE Cream 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION Prompt institution of appropriate regimens for care of the burned patient is of prime importance and includes the control of shock and pain. The burn wounds are then cleansed and debrided, and SILVADENE Cream 1% (silver sulfadiazine) is applied under sterile conditions. The burn areas should be covered with SILVADENE Cream 1% at all times.
The cream should be applied once to twice daily to a thickness of approximately 1/16 inch. Whenever necessary, the cream should be reapplied to any areas from which it has been removed by patient activity. Administration may be accomplished in minimal time because dressings are not required. However, if individual patient requirements make dressings necessary, they may be used.
Reapply immediately after hydrotherapy. Treatment with SILVADENE Cream 1% should be continued until satisfactory healing has occurred, or until the burn site is ready for grafting. The drug should not be withdrawn from the therapeutic regimen while there remains the possibility of infection except if a significant adverse reaction occurs.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosing: Pediatric
Pediatric use (US label) US FDA label
Pediatric Use Safety and effectiveness in pediatric patients have not been established (see CONTRAINDICATIONS).
Dosing: Older adult
Geriatric use (US label) US FDA label
Geriatric Use Of the total number of subjects in clinical studies of SILVADENE Cream 1%, seven percent were 65 years of age and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Dosage forms
Philippines
- Cream: 1 g/100 g, 10 mg/1 g, 10 mg/g
- Topical cream: 1 g/100 g, 10 mg/g
- W/w cream: 10 mg/g
- W/w topical cream: 10 mg/g
- W/w) topical cream: 10 mg/g (1 %
Registered products in the Philippines
59 products registered with the Food and Drug Administration (FDA) Philippines list Silver sulfadiazine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Silver Sulfadiazone (1 product). Products registered under these spellings are included in the table and marked.
All registered products59
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AccediazineSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 25 g (Box of 1's) | Rx | OPAL Laboratories Pvt LtdPakistan | Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-14305 | Aug 16, 2028 | |
AgyzideSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamLaminated Tube x 15 g, 20 g, 25 g, and 30 g | Rx | Nanz Med Science Pharma Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-16311 | Feb 4, 2030 | |
AmidozilSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream15 g (net content) aluminum collapsible tube (box of 1's) | Rx | S Kant Healthcare LimitedIndia | Triple Tact Import & Export Corp. | DRP-15249 | May 31, 2029 | |
ArgyrexSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamLaminated Tube 30 g x l's (Box of 1's) | Rx | Lincoln Pharmaceuticals Ltd.India | Despina Pharma Inc. | DRP-12818 | Oct 10, 2027 | |
BlazineSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream30g (net content) laminated tube with white PE cap (Box of 1 's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-15347-03 | Jun 26, 2029 | |
BsilverSilver sulfadiazine | 10 mg/g (1% w/w) CreamLaminated tube x 15 g (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPCTrader: BSD Global Pte. Ltd. | DRP-17356 | Nov 14, 2030 | |
BuradocSilver Sulfadiazine | 10 mg/g (1% w/w) Cream100 g lami tube (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPC | DRP-16663 | Jun 3, 2030 | |
BurnsilSilver Sulfadiazine | 10 mg/g Cream (1% w/w)Aluminum Tube x 25 g (Box of 1's) | Rx | Beximco Pharmaceuticals LimitedBangladesh | Euro Generics International Phils., Inc. | DRP-1559 | Jan 29, 2029 | |
BurnzineSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 20 g (Box of 1’s) | Rx | Agio Pharmaceuticals Ltd.India | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-3701-02 | Aug 26, 2037 | |
BurnzineSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamAluminum Collapsible Tube x 20 g (Box of 1’s) | Rx | Azine Healthcare Pvt. Ltd.India | TGP Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13062-01 | Nov 24, 2027 | |
CurezineSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream15 g Aluminum Collapsible Tube (Box of 1's) | Rx | S Kant Healthcare LimitedIndia | Curecare Pharmaceutical Products DistributionImporter: Orange Biotec Inc. | DRP-13630-01 | Mar 22, 2028 | |
DermasilSilver Sulfadiazine | 10 mg / g (1% w/w) Topical CreamAluminum Collapsible Tube x 10 g, 15 g and 20 g (Box of 1's) | Rx | Fredun Pharmaceuticals LimitedIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-16357-01 | Feb 25, 2030 | |
FaradermSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream30 g (net content) laminated tube with white PE cap (box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec, Inc. | DRP-15347 | Jun 26, 2029 | |
FlamavidSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream20 g Polyethylene, Aluminum and Copolymer Laminated Tube (Box of 1's) | Rx | Winston Medical Supply Co., Ltd.China | Hovid Inc. | DRP-12054 | Jun 27, 2027 | |
FlamavidSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream500 g Polypropylene (PP) Bottle (Jar) with Low Density Polyethylene (LDPE) Lid | Rx | Winston Medical Supply Co., Ltd.China | Hovid Inc. | DRP-12055 | Jun 27, 2027 | |
FlamizinSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamAluminum Collapsible Tube x 5 g and 25 g (Box of 1's) | Rx | Bal Pharma LimitedIndia | Endure Medical Inc.Importer: Singapore Genebio Inc. | DR-XY44363 | Mar 25, 2030 | |
FlammasulSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamAluminum Collapsible Tube x 10 g, 15 g and 20 g (Box of 1's) | Rx | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-16357 | Feb 25, 2030 | |
FlammazineSilver Sulfadiazine | 10 mg/g (1% w/w) CreamPolyethylene Tube 5 g Box of 24’s | Rx | Recipharm Parets SL.Spain | Importer: A. Menarini Philippines, Inc. | DR-XY18547 | Mar 24, 2030 | |
FlammazineSilver Sulfadiazine | 10 mg/g (1%) CreamPolyethylene Tube x 20 g and 50 g (Box of 1’s) | Rx | Recipharm Parets SLUSpain | Importer: A. Menarini Philippines, Inc. | DR-XY18914 | Feb 12, 2028 | |
FlammazineSilver Sulfadiazine | 10 mg/g CreamPolypropylene Jar x 500 g | Rx | Recipharm Parets SLSpain | Importer: A. Menarini Philippines, Inc. | DR-9900 | May 30, 2027 | |
FlovidiazineSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 20 g (Box of 1’s) | Rx | Agio Pharmaceuticals Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-3701-03 | Sep 11, 2037 | |
FyrazineSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream30 g (net content) laminated tube with white PE cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-15347-02 | Jun 26, 2029 | |
GodiazineSilver Sulfadiazine | 10mg/g (1% w/w) Topical Cream30 g (net content) Laminated tube with white PE cap (Box of 1’s) | Rx | Magbro Healthcare Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Pharmakon Biotec Inc. | DRP-15347-04 | Jun 26, 2029 | |
InnoxidermSilver Sulfadiazine | 10 mg/1 g (1%) CreamCollapsible printed aluminum tube 20 g and 2 g (as Physician's sample) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innoderm, Inc. | DR-XY22791 | Apr 21, 2027 | |
InnoxidermSilver Sulfadiazine | 10 mg/g (1%) CreamPlastic Jar x 500 g NA | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innoderm, Inc. | DR-XY42531 | Oct 26, 2030 | |
LorvazineSilver Sulfadiazine | 1 g/100 g (1% w/w) Topical CreamAluminum Tube X 25 g (Box of 1's) | Rx | T.O. Chemicals (1979) Ltd.Thailand | Lordla Pharma Sales | DR-XY23837 | Feb 6, 2028 | |
MAZINESILVER SULFADIAZINE | 10 mg/g (1% w/w) Cream | Rx | GLOBAL PHARMACEUTICALS (PVT) LTD. | SURESTEP PHARMACEUTICALS, INC. | DR-XY40687 | Feb 27, 2027 | |
NoneSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 25 g (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-14305-01 | Aug 16, 2028 | |
RetasildexSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream20 g Collapsible Aluminum Tube (Box of 1's) | Rx | S Kant Healthcare LimitedIndia | Reta DrugImporter: Aglobal Care, Inc. | DRP-8116-4 | Jan 15, 2028 | |
RevsilSilver Sulfadiazine | 10 mg/g (1% w/w) CreamCollapsible Aluminum Tube x 5g, 10g, and 15g (Box of 1's); Collapsible Aluminum Tube x 20g (Net content: 15g) (Box of l's) | Rx | LifeSquare Laboratories, Inc.Philippines | — | DRP-11019 | Jan 18, 2027 | |
SildazinSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamLaminated Tube 30 g x 1’s (Box of 1's) | Rx | Lincoln Pharmaceuticals Ltd.India | Epione Lifecare Inc.Importer: Despina Pharma Inc. | DRP-12818-01 | Oct 10, 2027 | |
SildiazSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream15 g and 20 g Collapsible Aluminum Tube (Box of 1's) | Rx | S. KANT HEALTHCARE LTD.India | BELLUS LIFE SOLUTIONS, INC.Importer: AGLOBAL CARE, INC. | DRP-8116-01 | Jan 15, 2028 | |
SildineSilver Sulfadiazine | 10 mg/g (1% w/w) Cream100 g lami tube (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPC | DRP-16664 | Jun 3, 2030 | |
SilfavexSilver Sulfadiazine | 10 mg/g (1%) Cream500 g contained in a black polybag inside a gray HDPE jar | Rx | Agio Pharmaceuticals LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-2178-05 | Aug 6, 2037 | |
SilvakhrizSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamAluminum laminated tube x 25g and 50g | Rx | Rhydburg Pharmaceuticals Ltd.India | Khriz Pharma Trading, Inc. | DRP-11454 | Mar 14, 2027 | |
SilvapexSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Collapsible Tube X 30 g (Box of 1's) | Rx | Daiwik Pharmasphere Pvt. Ltd.India | FSPC Pharmaceuticals Inc. | DRP-17953 | Apr 15, 2031 | |
SilvedermaSilver Sulfadiazine | 1 g/100 g (1% w/w) CreamPlastic Jar x 500 g (Box of 1's) | Rx | Laboratorio Aldo Union, S.L.Spain | The Cathay Drug Co., Inc. | DR-XY36319 | Jul 23, 2029 | |
10mg/g (1% w/w) Topical Cream15 g and 20 g Collapsible Aluminum Tube (Box of 1's) | Rx | S. Kant Healthcare LimitedIndia | The Cathay Drug Co., Inc.Importer: Aglobal Care Inc. | DRP-8116-02 | Jan 15, 2028 | ||
SilvedexSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream15 g and 20 g Collapsible Aluminum Tube (Box of 1's) | Rx | S. Kant Healthcare Limited.India | AGlobal Care, Inc. | DRP-8116 | Jan 15, 2028 | |
SilversaphSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamAluminum Collapsible Laminated Tube x 15g, 20g and 25g (Box of 1's) | Rx | Sai Parenterals Ltd.India | Nelpa Lifesciences Inc. | DRP-17050 | Sep 12, 2030 | |
SilversaphSilver Sulfadiazine | 10mg/g (1% w/w) Topical CreamAluminum Collapsible Tube x 15 g, 20 g, and 25 g (Box of 1's) | Rx | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-13062 | Nov 24, 2027 | |
SilvertinSilver Sulfadiazine | 10 mg/g (1% w/w) CreamCollapsible Aluminum Tube X 20 g with white cap (Box of 1's) | Rx | Antila Lifesciences Pvt. Ltd.India | ELISET PHARMACEUTICAL, INC.Importer: AGLOBAL CARE, INC. | DR-XY46296 | Apr 5, 2028 | |
SilvexSilver Sulfadiazine | 10 mg/g (1% w/w) CreamHDPE Jar x 250 g N/A | Rx | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-10168 | Aug 14, 2031 | |
SilvexSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 20 g (Box of 1’s) | Rx | Agio Pharmaceuticals Ltd.India | Macropharma CorporationImporter: Ambica International Corporation | DRP-3701 | Aug 14, 2031 | |
SilvexSilver Sulfadiazine | 10 mg/g (1%) Cream500 g contained in a black polybag inside a gray HDPE jar | Rx | Agio Pharmaceuticals Ltd.India | Macropharma CorporationImporter: Ambica International Corporation | DRP-2178 | Mar 1, 2038 | |
SilviSilver Sulfadiazine | 10 mg/g (1% w/w) Cream100 g lami tube (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Genedrift Philippines OPC | DRP-16665 | Jun 3, 2030 | |
SilvirinSilver Sulfadiazine | 10 mg/g (1%) w/w Cream20 g Aluminum Collapsible Tube (Box of 1's) | Rx | Raptakos Brett & Co. Ltd.India | Raptakos, Brett & Co., Ltd. | DR-XY49144 | Aug 1, 2029 | |
SisuldaSilver Sulfadiazine | 10 mg/g (1%) w/w Topical Cream15 g Aluminum Collapsible Tube (Box of 1's) | Rx | S Kant Healthcare LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-13630 | Mar 22, 2028 | |
SterizolSilver Sulfadiazine | 10 mg/g (1% w/w) CreamPlatic Jar (500 g) | Rx | Ashford Pharmaceuticals Laboratories Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DRP-671 | Aug 9, 2029 | |
SuldaxiSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamPlastic Round Jar x 500 g (Box of 1's) | Rx | S Kant Healthcare LimitedIndia | Aglobal Care, Inc. | DRP-12993 | Nov 15, 2027 | |
SulfadexSilver Sulfadiazine | 10 mg/g (1%w/w) Topical CreamAluminum Tube x 20 g (Box of 1's) | Rx | Dong Wha Pharm Co., Ltd.Korea | Endure Medical, Inc. | DR-XY47556 | Nov 22, 2026 | |
SulfasaveSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 25 g (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma And Trading Co.Importer: Accesspoint International Trading Inc. | DRP-14305-02 | Aug 16, 2028 | |
SulmazinSilver Sulfadiazine | 10 mg/g (1% w/w) Topical CreamPolypropylene Jar x 500 g | Rx | Dong Wha Pharm. Co., Ltd.Republic of Korea | Endure Medical, Inc. | DR-XY46424 | Sep 20, 2028 | |
SulverSilver Sulfadiazine | 10 mg/g (1%) Cream500 g contained in a black polybag inside a gray HDPE jar | Rx | Agio Pharmaceutical LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-2178-03 | Jun 3, 2037 | |
SynvodexSilver Sulfadiazine | 10 mg/g (1% w/w) CreamAluminum Tube x 20 g (Box of 1’s) | Rx | Agio Pharmaceuticals Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3701-04 | Sep 22, 2037 | |
TopisulfaSilver Sulfadiazine | 10 mg/g (1%) Cream500 g contained in a black polybag inside a gray HDPE jar N/A | Rx | Agio Pharmaceutical LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-2178-04 | Aug 17, 2037 | |
VexsilvaSilver Sulfadiazine | 10 mg/g (1% w/w) CreamWhite Plastic Laminated Tube x 5 g & 20 g (Box of 1's) | Rx | Yash PharmaceuticalsIndia | VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd. | DR-XY49101 ` | May 31, 2029 | |
ZylfacareSilver Sulfadiazine | 10 mg/g (1% w/w) Topical Cream15 g and 20 g Collapsible Aluminum Tube (Box of 1's) | Rx | S Kant Healthcare LimitedIndia | Medcare PharmaceuticalsImporter: Aglobal Care, Inc. | DRP-8116-05 | Jan 15, 2028 | |
(no brand name)Silver Sulfadiazine | 10mg/g (1 % w/w) Topical CreamAluminum laminated tube x 50g | Rx | Rhydburg Pharmaceuticals Ltd.India | Sahar International Trading, Inc. | DRP-11420 | Mar 10, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS Absorption of silver sulfadiazine varies depending upon the percent of body surface area and the extent of the tissue damage. Although few have been reported, it is possible that any adverse reaction associated with sulfonamides may occur. Some of the reactions, which have been associated with sulfonamides, are as follows: blood dyscrasias including agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, and hemolytic anemia; dermatologic and allergic reactions, including life-threatening cutaneous reactions [Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and exfoliative dermatitis]; gastrointestinal reactions; hepatitis and hepatocellular necrosis; CNS reactions; and toxic nephrosis.
There is potential cross-sensitivity between silver sulfadiazine and other sulfonamides. If allergic reactions attributable to treatment with silver sulfadiazine occur, continuation of therapy must be weighed against the potential hazards of the particular allergic reaction. Fungal proliferation in and below the eschar may occur.
However, the incidence of clinically reported fungal superinfection is low. The use of SILVADENE Cream 1% (silver sulfadiazine) in some cases of glucose-6-phosphate dehydrogenase-deficient individuals may be hazardous, as hemolysis may occur.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Several cases of transient leukopenia have been reported in patients receiving silver sulfadiazine therapy. 1,2,3 Leukopenia associated with silver sulfadiazine administration is primarily characterized by decreased neutrophil count. Maximal white blood cell depression occurs within 2 to 4 days of initiation of therapy.
Rebound to normal leukocyte levels follows onset within 2 to 3 days. Recovery is not influenced by continuation of silver sulfadiazine therapy. An increased incidence of leukopenia has been reported in patients treated concurrently with cimetidine. Other infrequently occurring events include skin necrosis, erythema multiforme, skin discoloration, burning sensation, rashes, and interstitial nephritis.
Reduction in bacterial growth after application of topical antibacterial agents has been reported to permit spontaneous healing of deep partial-thickness burns by preventing conversion of the partial thickness to full thickness by sepsis. However, reduction in bacterial colonization has caused delayed separation, in some cases necessitating escharotomy in order to prevent contracture.
Pregnancy considerations
Pregnancy (US label) US FDA label
Pregnancy Teratogenic Effects. A reproductive study has been performed in rabbits at doses up to three to ten times the concentration of silver sulfadiazine in SILVADENE Cream 1% and has revealed no evidence of harm to the fetus due to silver sulfadiazine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly justified, especially in pregnant women approaching or at term (see CONTRAINDICATIONS).
Breastfeeding considerations
Lactation (US label) US FDA label
Nursing Mothers It is not known whether silver sulfadiazine is excreted in human milk. However, sulfonamides are known to be excreted in human milk, and all sulfonamide derivatives are known to increase the possibility of kernicterus. Because of the possibility for serious adverse reactions in nursing infants from sulfonamides, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pharmacokinetics
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram-negative and gram-positive bacteria as well as being effective against yeast. Results from in vitro testing are listed below. Sufficient data have been obtained to demonstrate that silver sulfadiazine will inhibit bacteria that are resistant to other antimicrobial agents and that the compound is superior to sulfadiazine.
Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect.
Results of In Vitro Testing with SILVADENE ® Cream 1% (silver sulfadiazine) Concentration of Silver Sulfadiazine Number of Sensitive Strains/Total Number of Strains Tested Genus & Species 50 μg/mL 100 μg/mL Pseudomonas aeruginosa 130/130 130/130 Xanthomonas (Pseudomonas) maltophilia 7/7 7/7 Enterobacter species 48/50 50/50 Enterobacter cloacae 24/24 24/24 Klebsiella species 53/54 54/54 Escherichia coli 63/63 63/63 Serratia species 27/28 28/28 Proteus mirabilis 53/53 53/53 Morganella morganii 10/10 10/10 Providencia rettgeri 2/2 2/2 Providencia species 1/1 1/1 Proteus vulgaris 2/2 2/2 Citrobacter species 10/10 10/10 Acinetobacter calcoaceticus 10/11 11/11 Staphylococcus aureus 100/101 100/101 Staphylococcus epidermidis 51/51 51/51 β-Hemolytic Streptococcus 4/4 4/4 Enterococcus species 52/53 53/53 Corynebacterium- diphtheriae 2/2 2/2 Clostridium perfringens 0/2 2/2 Candida albicans 43/50 50/50 Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Silver Sulfadiazine Cream 1%, 15 g Tube | ₱61.22–₱64.77Reference ₱61.22 | per tube | DPRI procurement range |
| Silver Sulfadiazine Cream 1%, 25 g Tube ● | ₱56.44–₱125.00Reference ₱69.11 | per tube | DPRI procurement range |
| Silver Sulfadiazine Cream 1%, 500 g Jar | ₱750.00–₱930.00Reference ₱870.00 | per jar | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Silver Sulfadiazine |
| PNF listing | Cream: 1%, 15 g and 25 g tube |
| PNF listing | Cream: 500 g jar (micronized) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. SILVADENE · Pfizer Laboratories Div Pfizer Inc [US FDA-approved label, version 19, January 26, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c437213a-1cd4-445e-a39f-bbcacb9f746f
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .